InvestSMART

Cryosite Limited (ASX: CTE) - Share Price

- Current share price for CTE : $1.150

Cryosite Limited (CTE), an ASX-listed company, provides specialized, temperature-controlled logistics and depot services, including secure storage, labelling, secondary packaging, import/export coordination, inventory management, distribution, destruction, and reverse logistics.

CTE General Information +

ASX Code CTE
Website http://www.cryosite.com
Industry/Sector Life Sciences Tools & Services
Market Cap ($M) 56
CTE Share Price $1.150
Day High $0.000
Day Low $0.000
Last Close $1.150
CTE Share Price Movement - ( No change )
Prices as at 16:40, 26 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Cryosite Limited (CTE) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 2¢ 0% 6 Sep 2024 10 Oct 2024 - - -
HFResult 1.5¢ 0% 7 Sep 2023 6 Oct 2023 - - -
HFResult 1¢ 0% 15 Sep 2022 14 Oct 2022 - - -

See all dividends from Cryosite Limited (CTE) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Cryosite Limited (CTE) price-sensitive announcements

CTE - Trading Update - Financial Year-to-Date - 30 April 2026
Cryosite Limited reported strong financial performance for the ten months ending 30 April
Cryosite Limited (CTE)
27 May 2026 | 8:53 AM
CTE - Appendix 4D and Half Year Accounts
Cryosite Limited's Appendix 4D and Half Year Accounts for the period ending 31 December 20
Cryosite Limited (CTE)
26 Feb 2026 | 5:26 PM
CTE - Trading Update - Q1 FY26
Cryosite Limited provided a trading update for the first quarter of the fiscal year 2026,
Cryosite Limited (CTE)
13 Oct 2025 | 10:01 AM
CTE - Acquisition of Strategic Warehouse Facility
Cryosite Limited announced the acquisition of a strategic warehouse facility located at 10
Cryosite Limited (CTE)
1 Oct 2025 | 11:14 AM

Cryosite Limited (CTE) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Cryosite Limited (CTE)
ORDINARY FULLY PAID
 Health Care $56 Trading Update - Financial Year-to-Date - 30 April 2026 27 May 2026 8:53AM $1.070 $1.150 risen by 7.48%
Cryosite Limited (CTE)
ORDINARY FULLY PAID
 Health Care $56 Notification regarding unquoted securities - CTE 18 Mar 2026 5:13PM $1.150 $1.150 fallen by 0%
Cryosite Limited (CTE)
ORDINARY FULLY PAID
 Health Care $56 Executive Director's Update - Half-Year FY26 Results 26 Feb 2026 5:38PM $1.200 $1.150 fallen by 4.17%
Cryosite Limited (CTE)
ORDINARY FULLY PAID
 Health Care $56 Appendix 4D and Half Year Accounts 26 Feb 2026 5:26PM $1.200 $1.150 fallen by 4.17%
Cryosite Limited (CTE)
ORDINARY FULLY PAID
 Health Care $56 Cryosite Completes Settlement of New Freehold Facility 27 Nov 2025 8:39AM $1.130 $1.150 risen by 1.77%
Cryosite Limited (CTE)
ORDINARY FULLY PAID
 Health Care $56 Notification regarding unquoted securities - CTE 23 Oct 2025 4:11PM $1.100 $1.150 risen by 4.55%

CTE Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A $1.88 $3.80 0.30% 21.70 0.00 0.00% 0.0%
2024A $1.84 $3.80 30.50% 19.00 2.00 2.80% 0.0%
2023A $1.41 $2.90 3.60% 24.50 1.50 2.10% 0.0%

CTE Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Cryosite Limited (CTE) $56M 0.0027 0.0000 0.0000 30.4233 0.0000 0.0000 0.00% 0.00% 0.00%

CTE Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.35 30.40 23.50 0.00
Market 0.29 13.30 1.15 0.66
Sector 0.42 26.20 2.41 2.34

CTE Directors

Name Position Start Date
Mr Andrew Kerr Executive Director 22 Feb 2024
Mr Mark Gregory Kerr Non-Executive Chairman, Non-Executive Director 8 Dec 2023
Mr Scott Thomas Non-Executive Director 9 May 2024

Cryosite Limited (CTE) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
27 Jun 2025 KERR, Mark Buy Indirect Shares 75,000 $0.745 $55,873.470
7 Apr 2025 KERR, Mark Buy Indirect Shares 231,453 $0.800 $185,131.360
21 Jun 2024 KERR, Mark Sell Indirect Shares 154,494 $1.050 $162,218.700

See all changes in directors' interest & trades for Cryosite Limited (CTE) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CTE Management

Name Position
Jane Hao Chief Financial Officer
Hamish George Company Secretary
Alicia Steel General Manager

CTE Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Cryosite Limited (CTE). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
13,043,702 (26.70%) Andrew John Kroger
9,306,453 (19.10%) Lindmark Investments Staff Superannuation Fund
4,377,408 (8.97%) Gary Griffith Robins
4,000,000 (8.20%) Laurie Thomas Family Nominees Pty Ltd

CTE Calendar of Events

Date Event
25 February 2027 Report (Interim)
20 August 2026 Report (Annual)
20 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.